POZEN Inc (POZN.OQ)
POZN.OQ on NASDAQ Stock Exchange Global Select Market
5.73USD
10:54am EDT
5.73USD
10:54am EDT
Price Change (% chg)
$-0.02 (-0.35%)
$-0.02 (-0.35%)
Prev Close
$5.75
$5.75
Open
$5.78
$5.78
Day's High
$5.78
$5.78
Day's Low
$5.67
$5.67
Volume
2,852
2,852
Avg. Vol
48,417
48,417
52-wk High
$6.94
$6.94
52-wk Low
$4.28
$4.28
About
POZEN Inc. (POZEN), is a pharmaceutical company focused on transforming medicine. The Company had developed Treximet in collaboration with GlaxoSmithKline (GSK). Treximet is the brand name for the product combining sumatriptan 85 milligram, formulated with RT Technology and naproxen sodium 500 milligram in a single tablet... (more)
Overall
| Beta: | 1.38 |
| Market Cap (Mil.): | $174.61 |
| Shares Outstanding (Mil.): | 30.37 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| POZN.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 47.13 | 37.76 |
| EPS (TTM): | -0.75 | -- | -- |
| ROI: | -25.63 | -2.58 | 18.76 |
| ROE: | -25.63 | -2.66 | 19.59 |
Competitors
| Price | Change | |
|---|---|---|
| Pfizer Inc. (PFE.N) | $29.18 | -0.05 |
| Johnson & Johnson (JNJ.N) | $93.90 | +0.40 |
| Merck & Co., Inc. (MRK.N) | $48.13 | -0.04 |
| AstraZeneca plc (AZN.L) | 3,311.50p | -23.50 |
| GlaxoSmithKline plc (GSK.L) | 1,706.50p | +22.50 |
| Endo Health Solutions Inc (ENDP.OQ) | $38.95 | +0.49 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

